↓ Skip to main content

Postoperative tamoxifen for ductal carcinoma in situ

Overview of attention for article published in Cochrane database of systematic reviews, October 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 tweeters
f1000
1 research highlight platform

Citations

dimensions_citation
38 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Postoperative tamoxifen for ductal carcinoma in situ
Published in
Cochrane database of systematic reviews, October 2012
DOI 10.1002/14651858.cd007847.pub2
Pubmed ID
Authors

Helen Staley, Iain McCallum, Julie Bruce

Abstract

Ductal carcinoma in situ (DCIS) is a non-invasive carcinoma of the breast. The incidence of DCIS has increased substantially over the last twenty years, largely as a result of the introduction of population-based mammographic screening. The treatment of DCIS tumours involves surgery with or without radiotherapy to prevent recurrent DCIS and invasive carcinoma. However, there is clinical uncertainty as to whether postoperative hormonal treatment (tamoxifen) after surgery confers benefit in overall survival and incidence of recurrent carcinoma.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 110 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 20 18%
Student > Master 18 16%
Student > Bachelor 15 14%
Student > Ph. D. Student 13 12%
Other 10 9%
Other 20 18%
Unknown 15 14%
Readers by discipline Count As %
Medicine and Dentistry 50 45%
Nursing and Health Professions 11 10%
Psychology 6 5%
Biochemistry, Genetics and Molecular Biology 5 5%
Agricultural and Biological Sciences 5 5%
Other 14 13%
Unknown 20 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2013.
All research outputs
#4,372,567
of 15,157,504 outputs
Outputs from Cochrane database of systematic reviews
#7,132
of 11,123 outputs
Outputs of similar age
#41,423
of 153,467 outputs
Outputs of similar age from Cochrane database of systematic reviews
#56
of 100 outputs
Altmetric has tracked 15,157,504 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 11,123 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.8. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 153,467 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.